High Contrast

Newsroom
Events
Subscribe
Solutions and services
Insights
About RSM
Careers
Contact RSM

Article

Maximizing value through compliance: Strategic insights for life sciences leaders

Safeguarding and enhancing your business

November 14, 2024
#
Internal audit Life sciences

For growing life sciences companies, having a robust compliance strategy is essential for navigating the complex regulatory landscape, ensuring product safety and quality, protecting the company’s reputation, and mitigating legal and financial risks. The following guide outlines how biopharma and medtech companies can maximize their organizational value through smart compliance planning.

Why compliance matters

Biopharma and medtech businesses create value every day, whether or not they have a U.S. Food and Drug Administration-approved product in the market. That value is partially realized when clinical-stage companies go public, or when multiple rounds of investor funding are successfully completed before FDA approval. For those companies that go public, a very basic governance infrastructure is statutorily required that includes standard policies, many of which can be pulled from the public domain. There is no preliminary measure to determine whether those initial basic policies have been appropriately socialized throughout the organization or if they are followed.

If that’s true (and it is), then what is the purpose of policies, procedures or compliance?

Policies and procedures work together to create a company standard for doing business. They inform employees of regulatory requirements and provide standardized processes that, if followed, should produce a predictable result. Compliance in the biopharma and medtech sectors is the function responsible for ensuring that company policies and procedures reflect regulatory requirements and guidance issued by enforcement agencies.

Compliance in the life sciences industry

Within the life sciences industry, biopharma and medtech companies may vary greatly in appearance and objectives. However, they all share one crucial concern: the importance of preserving value. To this end, compliance serves as a vital protective mechanism. Here are a few examples of compliance goals and advantages:

Initiating your compliance journey

Although a comprehensive risk assessment is ideal, simply answering a few key questions can often determine the necessity to start integrating compliance principles immediately.

  • Is there a standardized process by which the company establishes relationships, particularly with health care providers and other researchers?
  • Do internal medical personnel communicate externally with the scientific, medical or patient community?
  • Has the management team been challenged by the board to provide a compliance plan that addresses the risks of the commercial plan?
  • Does the company have a field salesforce actively promoting one or more FDA-approved prescription products?
  • Is the company conducting or planning to conduct speaker programs, advisory boards or any other external engagements that involve meals, honoraria and/or travel?

Getting started

Establishing a compliance program does not require a uniform approach and it does not need to be completed all at once. Each company can gradually develop a compliance program that is appropriately scaled to its needs. However, intentional planning is crucial. This often begins with a preliminary gap analysis to inform the planning process, ensuring that the program evolves in a structured and effective manner.

The following four-step process has been shown to be effective in the establishment and maintenance of an effective compliance program.

1. Initial assessment

Step 1: Initial assessment

In most instances, companies will have some governance structure in place that can possibly continue to be leveraged. It is important, however, to have an initial assessment to objectively determine how current policies and procedures stack up against industry standards. An initial assessment by external industry experts is a recommended start.

2. Gap analysis

Step 2: Gap analysis

By leveraging the output from Step 1, a comparison should be performed between all applicable regulatory and enforcement agency guidance based on current and planned commercial activities and the current state of the company’s guidance documentation.

3. Action plan development

Step 3: Action plan development

An action plan can be developed detailing the road that bridges the “current state” to the “desired state” of the company’s policies and procedures, driven by company goals, by the tactics outlined in the candidate/product plan and by the timing of execution.

4. Action plan execution

Step 4: Action plan execution

Executing the action plan typically involves developing and implementing new policies and procedures, which includes the development and delivery of employee training. The timing of each element of the action plan should mirror the company’s evolution and can be stretched over multiple years.

Step 1: Initial assessment

In most instances, companies will have some governance structure in place that can possibly continue to be leveraged. It is important, however, to have an initial assessment to objectively determine how current policies and procedures stack up against industry standards. An initial assessment by external industry experts is a recommended start.

Step 2: Gap analysis

By leveraging the output from Step 1, a comparison should be performed between all applicable regulatory and enforcement agency guidance based on current and planned commercial activities and the current state of the company’s guidance documentation.

Step 3: Action plan development

An action plan can be developed detailing the road that bridges the “current state” to the “desired state” of the company’s policies and procedures, driven by company goals, by the tactics outlined in the candidate/product plan and by the timing of execution.

Step 4: Action plan execution

Executing the action plan typically involves developing and implementing new policies and procedures, which includes the development and delivery of employee training. The timing of each element of the action plan should mirror the company’s evolution and can be stretched over multiple years.

A culture of compliance

Many biopharma and medtech companies use slogans and marketing taglines to foster trust with their target patient population. Trust is paramount—without it, patients would hesitate to use medications or accept implants. At the core of this trust lies a robust compliance program. A thoughtful, well-executed compliance program that addresses risks inherent in commercial and medical activities can be the key to establishing a culture of compliance.

Trust = value

Failure to recognize the connection between trust and value can be a fatal oversight for a biopharma or medtech company. There are numerous examples of companies whose actions eroded the public trust and the result was a direct impact on their market value. An effective compliance environment can be instrumental in managing that risk.

Company culture matters

Trust stems directly from company culture. Companies that consciously foster a culture of compliance by rigorously enforcing rules establish a strong ethical and integrity framework. In such environments, doing the right thing becomes the norm, encouraged and rewarded by the organization. This commitment not only builds trust but also simplifies adherence to ethical standards.

Compliance is enabling

Well-informed professionals move with speed and certainty when they are clear on the guidelines. Ambiguity typically causes hesitation, which in a fast-paced business, can be the difference between winning and losing. An effective compliance environment can enable this by keeping employees informed and engaged in clarifying discussions that illuminate otherwise unclear dilemmas.

Working with RSM: Supporting your compliance needs

RSM has resources that can support your unique compliance journeys. While each client’s process may have similar steps, the speed, size and details are unique to each client. Our expectation is to create “fit-for-purpose” compliance programs that are consistent with each client’s unique culture.

Our life sciences compliance advisory provides the following services:

Compliance program

  • Compliance program planning and execution: RSM can work with you to strategically map out the progression of the compliance function over time and support its execution.
  • Compliance program assessment: For clients with existing programs, RSM can perform assessments against leading practices and authoritative recommendations.
  • Policies and procedures: RSM can support the development of policy and procedure drafts, or evaluate implemented policies and procedures against regulatory requirements, guidance and best practices.

Field force monitoring

  • Salesforce monitoring support, including:
    • HCP targeting
    • Targeted email review
    • Call note review
    • Expense review
  • Field medical monitoring support, including:
    • Targeted email review
    • Field notes review
    • Medical response review
    • Expense review

 

Speaker programs

  • Policies and procedures: RSM can support the development of policy and procedure drafts, or evaluate implemented policies and procedures against regulatory requirements, guidance and industry standards addressing speaker programs.
  • Speaker program audits: Enforcement agencies continue to focus on speaker programs as a risky activity despite their ability to provide critical information to health care providers. Clients can use audits to identify weaknesses and address issues before they become systemic.

Fee-for-service arrangements

  • Policies and procedures: Our industry professionals can support the development of policy and procedure drafts, or evaluate implemented policies and procedures against regulatory requirements, guidance and industry standards addressing fee-for-service arrangements.
  • Fee-for-service arrangements audits: Recommended frameworks for fee-for-service arrangements include several critical risk mitigaton steps. It is imperative that clients know whether all steps are being followed; reasons for why these steps are not being following must be clearly and fully documented. RSM can help.

 

Transparency reporting

  • Governance infrastructure: Our professionals can tailor a fit-for-purpose approach based on each
    client that includes policies with supporting procedures designed to inform employees of when and how to input data into systems in a way that makes it easy to extract for back-end reporting. RSM can also assist with training development and delivery.
  • Federal, state and local reporting support: RSM helps clients to find, aggregate and review spend data for completeness and accuracy to submit for applicable federal, state and local reporting.
  • Systems implementation: RSM teams match client needs to customizable technology solutions that include the flexibility to capture necessary data points upstream and enable downstream reporting requirements. Thinking through the endgame of required reporting during the implementation of new systems is the key to extracting full value from technological investments.

Staying one step ahead

Biopharma and medtech companies invest significant resources in identifying, developing, testing and ultimately launching prescription products. Throughout this journey, sound compliance efforts can significantly enhance both a company's value and the value of the products they develop. This increase in value is evident even before FDA approval, as reflected by movements in share price and subsequent rounds of venture capital investment.

Management teams should protect the value they are creating in their companies by establishing and maintaining a culture of compliance. Accomplishing this task requires a plan of intentional steps that help the organization to mature into an environment of internal control and predictable outcomes. This is not an overnight goal and it can progress at a pace that is comfortable for each company.

Are you ready for a more sustainable compliance strategy?

RSM will help you address compliance and regulatory risks before they impact your business.

Schedule your consultation today

THE POWER OF BEING UNDERSTOOD

ASSURANCE | TAX | CONSULTING

RSM US LLP is a limited liability partnership and the U.S. member firm of RSM International, a global network of independent assurance, tax and consulting firms. The member firms of RSM International collaborate to provide services to global clients, but are separate and distinct legal entities that cannot obligate each other. Each member firm is responsible only for its own acts and omissions, and not those of any other party. Visit rsmus.com/about for more information regarding RSM US LLP and RSM International.

© 2024 RSM US LLP. All rights reserved.